Zura(ZURA) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates HENDERSON, Nev. – (BUSINESS WIRE) – May 8, 2025 – Zura Bio Limited (Nasdaq: ZURA) ("Zura Bio" or the "Company"), a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for a range of autoimmune and inflammatory diseases, today reported financial results for the first quarter ended March 31, 2025, and provided recent corporate updates. "The first quarter of 2025 reflected steady ...